Literature DB >> 9077525

Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus.

D D Ivy1, T A Parker, J W Ziegler, H L Galan, J P Kinsella, R M Tuder, S H Abman.   

Abstract

Based on past studies of an experimental model of severe intrauterine pulmonary hypertension, we hypothesized that endothelin-1 (ET-1) contributes to high pulmonary vascular resistance (PVR), hypertensive lung structural changes, and right ventricular hypertrophy (RVH) caused by prolonged closure of the ductus arteriosus. To test this hypothesis, we studied the effects of BQ 123, a selective ET(A) receptor antagonist, after ligation of the ductus arteriosus in utero. In 19 late gestation fetal lambs (126+/-3 d; 147 d, term) we ligated the ductus arteriosus at surgery, and treated animals with either BQ 123 (1 mg/d) or vehicle (0.1% DMSO, HTN) in the pulmonary artery for 8 d. Chronic BQ 123 treatment attenuated the rise in mean pulmonary artery pressure (PAP) 8 d after ductus arteriosus ligation (78+/-2, HTN vs. 70+/-4 mmHg, BQ 123, P < 0.05). To study the effects of ET(A) blockade at birth, 15 animals were delivered by cesarean section and ventilated with 10% oxygen (O2), 100% O2 and inhaled nitric oxide (NO). Lambs treated with BQ 123 had lower PVR after delivery during ventilation with 10% O2, 100% O2, and inhaled NO (HTN vs. BQ 123, P < 0.05 for each intervention). Acute BQ 123 treatment (2 mg/30 min) lowered PVR in three HTN animals ventilated with 100% O2 and inhaled NO (P < 0.05). Chronic BQ 123 treatment prevented the development of RVH as determined by the ratio of the right ventricle/left ventricle + septum (0.79+/-0.03, HTN vs. 0.57+/-0.06, BQ 123, P < 0.05) and attenuated the increase in wall thickness of small pulmonary arteries (61+/-2, HTN vs. 50+/-2%, BQ 123, P < 0.05). In summary, chronic intrauterine ET(A) receptor blockade decreased PAP in utero, decreased RVH and distal muscularization of small pulmonary arteries, and increased the fall in PVR at delivery. We conclude that ET(A) receptor stimulation contributes to the pathogenesis and pathophysiology of experimental perinatal pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9077525      PMCID: PMC507931          DOI: 10.1172/JCI119274

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Tone-dependent responses to endothelin in the isolated perfused fetal sheep pulmonary circulation in situ.

Authors:  S Cassin; V Kristova; T Davis; P Kadowitz; G Gause
Journal:  J Appl Physiol (1985)       Date:  1991-03

2.  Polar secretion of endothelin-1 by cultured endothelial cells.

Authors:  O F Wagner; G Christ; J Wojta; H Vierhapper; S Parzer; P J Nowotny; B Schneider; W Waldhäusl; B R Binder
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

3.  Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation.

Authors:  H L Lippton; G A Cohen; I F McMurtry; A L Hyman
Journal:  J Appl Physiol (1985)       Date:  1991-02

4.  Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action.

Authors:  M W MacCumber; C A Ross; B M Glaser; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Endothelin-1 release from lamb ductus arteriosus: relevance to postnatal closure of the vessel.

Authors:  F Coceani; L Kelsey
Journal:  Can J Physiol Pharmacol       Date:  1991-02       Impact factor: 2.273

6.  Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes.

Authors:  H Ito; Y Hirata; M Hiroe; M Tsujino; S Adachi; T Takamoto; M Nitta; K Taniguchi; F Marumo
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

7.  Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome.

Authors:  P Cacoub; R Dorent; G Maistre; P Nataf; A Carayon; C Piette; P Godeau; C Cabrol; I Gandjbakhch
Journal:  Am J Cardiol       Date:  1993-02-15       Impact factor: 2.778

8.  Isolated pulmonary resistance vessels from fetal lambs. Contractile behavior and responses to indomethacin and endothelin-1.

Authors:  Y Wang; F Coceani
Journal:  Circ Res       Date:  1992-08       Impact factor: 17.367

9.  Endothelin-1-induced pulmonary arterial dilation is reduced by N omega-nitro-L-arginine in fetal lambs.

Authors:  M L Tod; S Cassin
Journal:  J Appl Physiol (1985)       Date:  1992-05

10.  Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs.

Authors:  S H Abman; P F Shanley; F J Accurso
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more
  23 in total

Review 1.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

Review 2.  How valid are animal models to evaluate treatments for pulmonary hypertension?

Authors:  Maria E Campian; Maxim Hardziyenka; Martin C Michel; Hanno L Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09       Impact factor: 3.000

Review 3.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

4.  Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension.

Authors:  David Wolf; Nancy Tseng; Gregory Seedorf; Gates Roe; Steven H Abman; Jason Gien
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-13       Impact factor: 5.464

5.  Update on PPHN: mechanisms and treatment.

Authors:  Jayasree Nair; Satyan Lakshminrusimha
Journal:  Semin Perinatol       Date:  2014-03       Impact factor: 3.300

6.  Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling.

Authors:  Jason Gien; Gregory J Seedorf; Vivek Balasubramaniam; Neil Markham; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2007-09-06       Impact factor: 21.405

Review 7.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

8.  Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep.

Authors:  Jason Gien; Nancy Tseng; Gregory Seedorf; Gates Roe; Steven H Abman
Journal:  Pediatr Res       Date:  2012-11-30       Impact factor: 3.756

9.  Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitro.

Authors:  Jason Gien; Gregory J Seedorf; Vivek Balasubramaniam; Nancy Tseng; Neil Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

10.  Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.

Authors:  Rio Dumitrascu; Silke Koebrich; Eva Dony; Norbert Weissmann; Rajkumar Savai; Soni S Pullamsetti; Hossein A Ghofrani; Arun Samidurai; Horst Traupe; Werner Seeger; Friedrich Grimminger; Ralph T Schermuly
Journal:  BMC Pulm Med       Date:  2008-12-17       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.